knowledge -WSS

knowledge

author：hotspot 2025-10-01 11:02:39 - browse：767

Sen. Bill Cassidy, R-La., listens during a Senate Health, Education, Labor, and Pensions Committee hearing. -- health policy coverage from STAT — Sen. Bill Cassidy (R-La.) Stefani Reynolds/The New York Times via AP

WASHINGTON — The top-ranking Republican on the Senate health committee is launching an investigation into two hospitals’ use of a government program that provides big drug discounts in return for serving low-income communities.

At the foundation of the debate over the so-called 340B program is whether Congress intended it to directly benefit low-income and uninsured patients or whether it was meant to help finance those hospitals, which could use the money as they see fit to add services.

Hospitals say they use the money to provide such services as free care for uninsured patients, free vaccinations, mental health clinics, and community health programs. But drugmakers have long argued that hospitals and chain pharmacies abuse the program and divert its cash flows to other uses. They also say the 340B program fuels the consolidation of health care systems as hospitals buy up private doctor practices to expand the 340B revenue stream.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Medical experts exlpore how to eliminate bias in clinical algorithms

hotspot

WSS

Mitch McConnell episode has important public health takeaway

Medical experts exlpore how to eliminate bias in clinical algorithms

Why do we get seasonal allergies?

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Eating disorder hotline's move to chatbot carried cost for volunteers

leisure time

knowledge

focus

Supreme Court strikes down use of affirmative action

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

BioMarin wins approval for gene therapy to treat hemophilia A

UnitedHealth wins $3.3 billion takeover of Amedisys

Duchenne breakthrough therapy leaves behind pioneering families

Mega Millions pot grows to $1.25 billion after no winner

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Micronoma's microbiome cancer diagnostic approach under fire

Medicare proposal to cover medical devices draws a mixed reaction

Trump indictment: Who are the 'co

Wikipedia

‘Oppenheimer’ and the risks of AI in health care

Supreme Court rules employers must be more accommodating of religious observance

No plane should take off without an EpiPen onboard

‘Oppenheimer’ and the risks of AI in health care

Pence says 'crackpot lawyers' told Trump what he wanted to hear

The simple reason for the increase in autism diagnosis

leisure time

hotspot

knowledge

entertainment